ARTICLE | Clinical News
GlycoDesign, Leo Pharma preclinical data
December 16, 2002 8:00 AM UTC
In rabbit arterial and venous thrombosis prevention models, GH9001 showed better safety and efficacy than enoxaparin low molecular weight heparin and the thrombin inhibitor hirudin. The compound is in...